18 who analyzed 1404 stage I–III colon cancer patients and found a frequency of KRAS mutations similar to our results but no prognostic impact on OS (P = 0.45). On the other hand, a study with 1989 patients concluded that KRAS mutation was associated with worse survival 19. Here, KRAS is linked to malignant colon neoplasm.